The Effectiveness and Safety in High-risk Patients Receiving First-line Atezolizumab and Bevacizumab Combined With HAIC for HCC: a Retrospective Study
Clinical trial NCT07272265 · COMPLETED
Trial details
- NCT number
- NCT07272265
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-28
- Primary completion
- 2025-05-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.